(Q33731688)

29 July 2017

1 reference

title

Management of diabetic neuropathy (English)

1 reference

29 July 2017

Parry GJ

1

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 August 1999

1 reference

American Journal of Medicine

29 July 2017

published in

1 reference

29 July 2017

volume

107

1 reference

29 July 2017

issue

2B

1 reference

29 July 2017

page(s)

27S-33S

1 reference

Does improved control of glycemia prevent or ameliorate diabetic polyneuropathy? Committee on Health Care Issues, American Neurological Association

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900010-8

Diabetic regulation and its relationship to microangiopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900010-8

Diabetic neuropathy and plasma glucose control.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900010-8

Diabetic neuropathy: Influence of age, sex, metabolic control, and duration of diabetes on motor conduction velocity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900010-8

Glycemic control and nerve conduction abnormalities in non-insulin-dependent diabetic subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900010-8

The natural history of somatosensory and autonomic nerve dysfunction in relation to glycaemic control during the first 5 years after diagnosis of type 1 (insulin-dependent) diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900010-8

Prevention of deterioration of renal and sensory-nerve function by more intensive management of insulin-dependent diabetic patients. A two-year randomised prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900010-8

Effects of continuous subcutaneous insulin infusion and intensified conventional therapy on peripheral and autonomic nerve dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900010-8

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900010-8

Reliability and Validity of a Diabetes Quality-of-Life Measure for the Diabetes Control and Complications Trial (DCCT)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900010-8

A self-controlled study of the effect of continuous subcutaneous insulin infusion on diabetic neuropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900010-8

Acute painful diabetic neuropathy precipitated by strict glycaemic control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900010-8

Hypoglycemic neuropathy in experimental diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900010-8

Effect of endocrine pancreas allotransplantation on diabetic nerve dysfunction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900010-8

The effect of pancreatic islet transplantation and insulin therapy on experimental diabetic autonomic neuropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900010-8

Effects of combined pancreatic and renal transplantation on diabetic neuropathy: a two-year follow-up study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900010-8

Effects of Pancreatic Transplantation on Diabetic Neuropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900010-8

Long-term effects of pancreatic transplantation on diabetic neuropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900010-8

Neuropathy and mortality in diabetes: Influence of pancreas transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900010-8

Are disturbances of sorbitol, phosphoinositide, and Na+-K+-ATPase regulation involved in pathogenesis of diabetic neuropathy?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900010-8

Aldose reductase inhibitors in the treatment of diabetic neuropathy. A review of the rationale and clinical evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900010-8

A meta-analysis of trials on aldose reductase inhibitors in diabetic peripheral neuropathy. The Italian Study Group. The St. Vincent Declaration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900010-8

Effect of near normoglycaemia for two years on progression of early diabetic retinopathy, nephropathy, and neuropathy: the Oslo study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900010-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9343(99)00010-8

1 reference

29 July 2017

1 reference